BSGM BioSig Technologies Inc.

Medical Device Company
1.09
-0.03  -3%
Previous Close 1.12
Open 1.14
52 Week Low 0.733
52 Week High 4.58
Market Cap $43,122,099
Shares 39,561,559
Float 35,097,001
Enterprise Value $37,367,101
Volume 150,001
Av. Daily Volume 250,907
Live cash est $88,666,444,222
Cash Burn N/A
No. Mths Cash 12
Insiders % 0.2
Total debt to equity 4.35
Earnings Date 01/01/2001
EPS 1.82
Rev guidance $10,459,000,000

Latest News

  1. Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) --

    • To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the United States
    • The Company adds new executives to accelerate sustained commercial momentum developing a national installed base of the PURE EP systems

    BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today issued a Letter to Shareholders providing highlights on the Company's recent developments and updates.

    Recent Company highlights include:

    • The growth…
    View Full Article
  2. Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company") a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that the Company would be exhibiting at Heart Rhythm 2022, due to take place on April 29 – May 1, 2022 at the Moscone Center in San Francisco, CA.

    Clinical observations collected by BioSig's PURE EP(TM) System will be featured in a poster presentation, titled Elimination Of Harmonic Ringing In Intracardiac Signals Using Dynamic Algorithmic Notch Filtering, and co-authored by Amin Al-Ahmad, M.D.; G Joseph Gallinghouse M.D.; Thomas Ladas, M.D…

    View Full Article
  3. Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, will be presenting at NobleCon18 - Noble Capital Markets' Eighteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida on Wednesday, April 20, 2022 at 9:30 AM ET. Conference attendees will also have the opportuntity to meet BioSig management during breakout sessions scheduled for 1:00 PM ET on Wednesday April 20, 2022.

    A high-definition,

    View Full Article
  4. BSGM)" src="https://www.getnews.info/wp-content/uploads/2022/03/1648566341.png" alt="This NASDAQ is Cardiac Worthy: Patent Protected Signal Processing Advancements for Cardiac Arrhythmia Nearing Commercialization: BioSig Technologies (NASDAQ:BSGM)" width="225" height="83" />
    • Developing Advanced Medical Technology to Improve Signal Fidelity and Uncover ECG and Intra-Cardiac Signals.

    • Completed New Share Offering to Finance Full Product Commercialization.  

    • US Patent Claims Awarded for PURE EP™ Noise-Filtering Technology.

    • Total of 49 Issued or Allowed Worldwide Patents Covering BSGM Tech.  

    • 30 Year Bio Industry Veteran John Sieckhaus Appointed as COO. 

    • Access Strategy to Enhance Market Access Strategy and Expand Installation Base…

    View Full Article
  5. Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced a new partnership agreement with Summit Blue Capital for implementing a leasing and finance program for the Company's PURE EP™ System.

    The Minneapolis-based Summit Blue Capital is a leader in equipment finance and leasing. It offers tailored leasing and financing solutions for its partners and clients in industries such as healthcare, manufacturing, hospitality, technology solutions, and more. Most notably, Summit Blue Capital…

    View Full Article
View All BioSig Technologies Inc. News